Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia

Stock Information for Solid Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.